Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs.
Latham NH, Doyle JS, Palmer AY, Vanhommerig JW, Agius P, Goutzamanis S, Li Z, Pedrana A, Gottfredsson M, Bouscaillou J, Luhmann N, Mazhnaya A, Altice FL, Saeed S, Klein M, Falade-Nwulia OO, Aspinall E, Hutchinson S, Hellard ME, Sacks-Davis R. Latham NH, et al. Among authors: luhmann n. Liver Int. 2019 Dec;39(12):2244-2260. doi: 10.1111/liv.14152. Epub 2019 Jun 10. Liver Int. 2019. PMID: 31125496
Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study.
Bouscaillou J, Kikvidze T, Butsashvili M, Labartkava K, Inaridze I, Etienne A, Le Pluart D, Kamkamidze G, Gamezardashvili A, Kharshiladze D, Avril E, Luhmann N. Bouscaillou J, et al. Among authors: luhmann n. Int J Drug Policy. 2018 Dec;62:104-111. doi: 10.1016/j.drugpo.2018.07.016. Epub 2018 Oct 30. Int J Drug Policy. 2018. PMID: 30384026
Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
Day E, Broder T, Bruneau J, Cruse S, Dickie M, Fish S, Grillon C, Luhmann N, Mason K, McLean E, Trooskin S, Treloar C, Grebely J. Day E, et al. Among authors: luhmann n. Int J Drug Policy. 2019 Apr;66:87-93. doi: 10.1016/j.drugpo.2019.01.012. Epub 2019 Feb 8. Int J Drug Policy. 2019. PMID: 30743093
Prevalence and management of tuberculosis among people who use drugs in Abidjan, Ivory Coast.
Bernier A, Perrineau S, Reques L, Kouamé A, N'Guessan R, N'Zi L, Diomandé M, Evanno J, Collin G, Deze C, Adjahi LP, Bouscaillou J, Luhmann N. Bernier A, et al. Among authors: luhmann n, n zi l, n guessan r. Int J Drug Policy. 2020 Sep;83:102862. doi: 10.1016/j.drugpo.2020.102862. Epub 2020 Jul 21. Int J Drug Policy. 2020. PMID: 32707477
141 results